查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018715

短讀定序市場：依產品、技術、最終用戶和應用分類－2026-2032年全球市場預測

Short-read Sequencing Market by Product, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，短讀定序市場價值將達到 78.4 億美元，到 2026 年將成長到 91.5 億美元，到 2032 年將達到 227.6 億美元，年複合成長率為 16.42%。

主要市場統計數據
基準年 2025 78.4億美元
預計年份：2026年 91.5億美元
預測年份 2032 227.6億美元
複合年成長率 (%) 16.42%

策略性應用凸顯了短讀定定序在調查、診斷和商業應用中的操作和科學重要性。

短讀長定序已從一項創新的實驗室技術發展成為現代分子生物學、臨床診斷和工業生物技術的基礎能力。化學、儀器和數據處理技術的進步提高了其容量、準確性和成本效益，使其能夠在所有研究、臨床和商業環境中進行常規應用。因此，從學術實驗室到大型製藥企業，相關人員都在重新思考工作流程、合作模式和資金分配，以便將定序驅動的洞見融入其核心營運中。

快速的技術進步、軟體的普及以及不斷演變的服務模式如何改變短讀定序的採用和價值交付。

短讀長定序領域正經歷著一場變革性的轉變，這主要由技術、監管和市場因素共同驅動。化學和儀器技術的進步不斷提高讀取準確率，降低批間差異，並簡化樣本製備流程，所有這些改進共同降低了分散式環境中應用該技術的門檻。同時，樣品製備盒和流動池設計的進步縮短了結果獲取時間，實現了臨床工作流程的快速週轉，並強化了定序在時間緊迫的診斷中的作用。

本研究評估了 2025 年美國關稅變化將如何影響整個定序生態系統的供應鏈韌性、採購定序和籌資策略。

美國2025年實施的新關稅和貿易措施，對依賴進口試劑、耗材和設備的企業而言，在合規性和成本管理方面提出了嚴峻挑戰。這些政策變化迫使採購團隊和供應商重新思考籌資策略，探索替代物流路線，並評估近岸外包和區域經銷夥伴，以減輕關稅相關價格波動的影響。隨著企業不斷調整，他們越來越重視合約柔軟性、供應商多元化和庫存管理，以維持業務永續營運。

整合細分洞察，揭示產品類型、定序技術、使用者畫像和應用模式如何共同塑造採用趨勢和價值鏈。

要了解市場動態，必須清楚掌握產品、技術、終端用戶和應用如何交織並塑造需求和採用模式。基於產品，市場可細分為耗材、儀器以及軟體和服務。耗材又可細分為流動池、試劑和樣品製備盒；儀器可細分為桌上型定序儀和高通量定序儀；軟體和服務可細分為生物資訊服務和資料分析軟體。從這個產品層面的架構可以看出，流程依賴性和試劑的持續消耗驅動著持續的收入模式，而儀器資本投資決策則受到處理能力、面積和整合功能的影響。

區域趨勢和政策環境解釋了美洲、歐洲、中東和非洲以及亞太市場在採用通路和供應商策略方面的差異。

區域趨勢在短讀長定序的應用、監管核准和商業化策略中發揮核心作用。在美洲，完善的研究基礎設施、廣泛的臨床試驗網路以及相對成熟的報銷機制，為定序在診斷和治療方法發現領域的快速應用提供了支持。生物技術中心和大型定序中心的集中，催生了對高通量設備和先進生物資訊學服務的需求。同時，採購慣例也更重視服務水準保證和與供應商建立長期夥伴關係。

主要企業如何將設備創新、耗材可靠性和分析服務結合，以建立整合平台和持久的客戶關係？

處於短讀長定序領域前沿的公司正透過整合平台功能、拓展服務範圍以及建立策略夥伴關係關係來加速臨床部署，從而實現差異化競爭優勢。領先的儀器製造商不斷提升通量、運作和自動化能力，而試劑和耗材製造商則專注於批間一致性、供應鏈透明度和精簡的工作流程，以減少對操作人員的依賴。提供檢驗的流程、可解讀的報告和安全資料管理的軟體和服務供應商正變得至關重要，尤其是在臨床和監管應用場景中。

產業領袖提出切實可行的建議，以增強供應鏈韌性、以客戶為中心的服務交付和臨床檢驗流程，從而促進永續部署。

產業領導者應優先考慮兼顧短期業務永續營運和長期策略定位的措施。首先，加強供應鏈多元化並建立區域製造或經銷夥伴關係，可以提高服務應對力，同時降低關稅和物流波動風險。其次，投資檢體、使用者友善的工作流程，涵蓋樣品製備、分析自動化和檢驗分析，可以降低臨床和分散式研究環境中採用這些流程的門檻，並加快獲得結果的速度。

高度透明的調查方法結合了第一手訪談、二手資訊檢驗和交叉細分分析，確保了可靠且可操作的見解。

本分析所依據的研究融合了定性和定量方法，以確保得出可靠且可重複的結論。主要研究包括對學術機構、臨床機構和商業機構的高階主管、實驗室經理、採購經理和技術專家進行結構化訪談。這些訪談提供了關於技術採納促進因素、檢驗要求、採購行為和營運挑戰的第一手觀點，為主題整合和情境分析奠定了基礎。

結論是：整合技術成熟度、營運韌性和協作策略，以實現短讀定序的價值。

總之，短讀長定序正處於成熟技術能力和不斷擴展的應用範圍的交匯點，在準確性、通量和成熟的分析生態系統之間實現了切實可行的平衡。試劑、儀器自動化和數據分析技術的持續改進正將其應用範圍從核心實驗室擴展到臨床和工業領域。同時，不斷變化的法規和關稅導致的供應鏈調整等外部因素正促使相關人員採取更具韌性的採購和檢驗措施。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 短讀定序市場：依產品分類

  • 消耗品
    • 流動池和試劑
    • 樣品製備工具包
  • 裝置
    • 桌上型音序器
    • 高通量定序儀
  • 軟體服務
    • 生物資訊服務
    • 數據分析軟體

第9章 短讀定序市場：依技術分類

  • 半導體定序
    • Ion Proton
    • Ion Torrent PGM
  • 接合性定序
  • 定序合成

第10章：短讀定序市場：依最終用戶分類

  • 學術和研究機構
  • 合約研究機構
  • 醫院/診斷檢查室
  • 製藥和生物技術公司

第11章 短讀定序市場：依應用領域分類

  • 表觀基因
    • 染色質可及性分析
    • DNA甲基化分析
  • 基因組學
    • 重測序
    • 目標序列
    • 全基因組定序
  • 總體基因體學
  • 轉錄組學

第12章 短讀定序市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 短讀定序市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 短讀定序市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國短讀定序市場

第16章：中國短序列定序市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eppendorf SE
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc.
  • Genewiz, Inc.
  • Hamilton Company
  • Illumina, Inc.
  • Macrogen, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Psomagen, Inc.
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AD36CD898498

The Short-read Sequencing Market was valued at USD 7.84 billion in 2025 and is projected to grow to USD 9.15 billion in 2026, with a CAGR of 16.42%, reaching USD 22.76 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.84 billion
Estimated Year [2026] USD 9.15 billion
Forecast Year [2032] USD 22.76 billion
CAGR (%) 16.42%

A strategic introduction highlighting the operational and scientific relevance of short-read sequencing across research, diagnostics, and commercial applications

Short-read sequencing has matured from a disruptive laboratory technique into a foundational capability that underpins modern molecular biology, clinical diagnostics, and industrial biotechnology. Advances in chemistry, instrumentation, and data processing have pushed throughput, accuracy, and cost-efficiency to levels that enable routine deployment across research, clinical, and commercial environments. As a result, stakeholders ranging from academic laboratories to large pharmaceutical companies are rethinking workflows, partnering models, and capital allocation to integrate sequencing-driven insights into core operations.

This introduction frames the strategic importance of short-read platforms by linking recent technological improvements to practical outcomes. Short-read approaches continue to offer high per-base accuracy, established bioinformatics ecosystems, and relative affordability for targeted and whole-genome assays. Consequently, they remain the preferred option for many standard applications even as long-read technologies gain traction in niche areas. Throughout this document, we adopt a lens that balances technical nuance with operational relevance, emphasizing how iterative improvements in reagents, instrumentation, and analytics combine to reshape decision-making horizons.

Through this perspective, readers will gain an understanding of where short-read sequencing delivers the greatest incremental value, how adoption patterns differ by user profile, and which strategic responses are most effective for organizations seeking to leverage sequencing as a competitive advantage. The following sections unpack the transformative shifts, policy impacts, segmentation logic, regional distinctions, leading corporate behaviors, actionable recommendations, and the research methodology that together support robust decision-making.

How rapid technological refinements, software democratization, and evolving service models are reshaping short-read sequencing adoption and value delivery

The landscape of short-read sequencing is experiencing transformative shifts driven by converging technological, regulatory, and market forces. Chemistry and instrument refinements have steadily improved read accuracy, reduced run-to-run variability, and simplified sample preparation, which collectively lower barriers to adoption in decentralized settings. Parallel advances in library preparation kits and flow cell design have shortened time-to-answer and enabled faster turnaround in clinical workflows, reinforcing sequencing's role in time-sensitive diagnostics.

At the same time, software innovations and cloud-native bioinformatics pipelines are democratizing access to advanced analysis, allowing smaller laboratories to apply complex variant calling, transcript quantification, and metagenomic profiling. Interoperability and standardized data formats are facilitating collaborative research and multi-center studies. Meanwhile, the competitive dynamic among instrument and reagent providers is accelerating product development cycles and expanding service offerings such as integrated sample-to-insight platforms.

Regulatory and reimbursement environments are also evolving; stricter validation requirements coexist with clearer pathways for diagnostic approval, which incentivizes vendors to invest in robust clinical utilities. Supply chain optimization and modular business models, including instrument-as-a-service and reagent subscriptions, are reshaping customer relationships. In short, the short-read sequencing ecosystem is shifting toward greater accessibility, higher integration, and more diverse commercialization models that collectively broaden its impact across scientific and clinical domains.

Assessing how United States tariff changes for 2025 are driving supply chain resilience, sourcing shifts, and procurement strategies across the sequencing ecosystem

The imposition of new tariffs and trade measures in the United States for 2025 has introduced a material compliance and cost-management dimension for organizations that rely on imported reagents, consumables, and instrumentation. These policy changes have prompted procurement teams and suppliers to reassess sourcing strategies, consider alternative logistics pathways, and evaluate nearshoring or regional distribution partnerships to mitigate exposure to tariff-driven price variability. As companies adjust, they increasingly emphasize contractual flexibility, multi-supplier qualification, and inventory management to sustain operational continuity.

In response to tariff pressures, some manufacturers have accelerated localization of production for high-volume consumables and critical components, while service providers have explored value-added logistics solutions to shield end users from sudden cost shifts. Regulatory scrutiny of supply chains has also risen, prompting enhanced documentation, supplier audits, and traceability measures that extend the timeline and complexity of vendor qualification processes. Consequently, capital planning cycles for laboratories and clinical adopters now account for potential tariff-related schedule and cost deviations.

Looking forward, the tariffs have catalyzed broader conversations about supply chain resilience, procurement governance, and strategic inventory posture. Organizations that proactively diversify supplier bases, engage in forward purchasing where appropriate, and collaborate with vendors on localized production and consignment models are better positioned to maintain consistent access to sequencing reagents and instruments while preserving budget predictability.

Integrated segmentation insights revealing how product types, sequencing technologies, user profiles, and application modalities together shape adoption and value chains

Understanding market dynamics requires a clear view of how products, technologies, end users, and applications intersect to shape demand and adoption patterns. Based on product, the market is examined across Consumables, Instruments, and Software & Services with Consumables further segmented into Flow Cells & Reagents and Library Prep Kits, Instruments separated into Benchtop Sequencers and High-Throughput Sequencers, and Software & Services divided into Bioinformatics Services and Data Analysis Software. This product-level framing reveals that procedural dependencies and recurring reagent consumption drive recurring revenue models, while instrument capital expenditure decisions hinge on throughput, footprint, and integration capability.

Based on technology, the landscape is charted across Semiconductor Sequencing, Sequencing Ligation, and Sequencing Synthesis, with Semiconductor Sequencing further characterized by platforms such as Ion Proton and Ion Torrent PGM. Each technology presents distinct trade-offs in read length, throughput, and run economics, which influence suitability for specific applications. Based on end user, the market encompasses Academic & Research Institutes, Contract Research Organizations, Hospitals & Diagnostic Labs, and Pharma & Biotech Companies, and this segmentation clarifies how purchasing cycles, validation demands, and service expectations vary across institutions.

Based on application, the analysis addresses Epigenomics, Genomics, Metagenomics, and Transcriptomics, further detailing Epigenomics into Chromatin Accessibility Analysis and DNA Methylation Analysis, and Genomics into Resequencing, Targeted Sequencing, and Whole Genome Sequencing. This application-focused perspective underscores how analytical priorities-such as depth versus breadth of coverage, sensitivity for rare variants, and throughput-determine the optimal constellation of products and services for a given use case. Integrating these segmentation lenses enables more precise market positioning, technology roadmapping, and customer engagement strategies.

Regional dynamics and policy environments explain distinct adoption pathways and vendor strategies across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics play a central role in shaping the deployment, regulatory acceptance, and commercial strategies for short-read sequencing. In the Americas, robust research infrastructure, wide availability of clinical trial networks, and relatively mature reimbursement pathways support rapid translation of sequencing into diagnostics and therapeutics discovery. The concentration of biotech hubs and large-scale sequencing centers creates demand for both high-throughput instruments and sophisticated bioinformatics services, while procurement practices emphasize service-level guarantees and long-term vendor partnerships.

In Europe, Middle East & Africa, regulatory diversity and varying levels of infrastructure investment create a heterogeneous adoption landscape. Western European markets often prioritize hospital integration and clinical validation pathways, whereas emerging markets in the region show strong academic research uptake and increasing interest from public health programs. Strategic partnerships that include training, local technical support, and adaptive pricing models accelerate broader adoption across these varied contexts. Regulatory harmonization efforts and cross-border research consortia are progressively smoothing integration challenges.

In Asia-Pacific, rapid capacity building, government-supported genomics initiatives, and strong manufacturing capabilities are accelerating both demand and local supply. High-throughput sequencing applications tied to population-scale studies and genomics-driven drug discovery are prominent, and regional providers are increasingly competitive on cost, localization, and scale. Across all regions, geographic considerations inform choices about inventory buffers, training programs, and deployment models, and vendors that tailor offerings to regional needs and policy environments gain a strategic advantage.

How leading companies combine instrument innovation, consumable reliability, and analytics services to build integrated platforms and durable customer relationships

Companies at the forefront of short-read sequencing are differentiating through integrated platform capabilities, expanded service offerings, and strategic partnerships that accelerate clinical adoption. Leading instrument manufacturers continue to iterate on throughput, run-time, and automation features, while reagent and consumable producers focus on lot-to-lot consistency, supply chain transparency, and streamlined workflows that reduce operator dependency. Service and software providers that deliver validated pipelines, interpretive reporting, and secure data management are becoming indispensable, especially for clinical and regulatory use cases.

Competitive positioning now extends beyond hardware to include recurring revenue models, cloud-enabled analytics, and co-development arrangements with large academic centers and pharmaceutical customers. As a result, some vendors are bifurcating their business models to serve high-throughput central laboratories while offering simplified benchtop solutions for point-of-care and smaller research settings. Partnerships with contract research organizations and localized distribution networks help many companies scale internationally while maintaining compliance and technical support standards.

Strategic acquisitions, collaborative development agreements, and investments in manufacturing redundancy are common tactics companies use to secure supply continuity and broaden technological portfolios. Firms that emphasize interoperability, open data standards, and comprehensive customer education programs earn greater trust among institutional buyers and clinical laboratories, which in turn supports deeper long-term relationships and recurring business.

Actionable recommendations for industry leaders to enhance supply resilience, customer-centric offerings, and clinical validation pathways that drive sustained adoption

Industry leaders should prioritize actions that balance near-term operational resilience with long-term strategic positioning. First, strengthening supply chain diversity and establishing regional manufacturing or distribution partnerships will reduce exposure to tariff and logistics volatility while improving service responsiveness. Second, investing in validated, user-friendly workflows-spanning sample prep, run automation, and standardized analytics-will lower the barrier to adoption across clinical and decentralized research settings and accelerate time-to-impact.

Third, building modular business models that offer both capital acquisition and subscription-based reagent or software services creates more predictable revenue streams and aligns vendor incentives with customer success. Fourth, companies should deepen collaborations with clinical networks and regulatory bodies to co-develop validation datasets and diagnostic use cases, thereby reducing time-to-market for clinical assays. Fifth, focusing on data interoperability, privacy-compliant cloud frameworks, and interpretive reporting will make sequencing outputs actionable for clinicians and researchers alike.

Finally, leaders must invest in workforce enablement through training, certification, and localized technical support to ensure customers achieve consistent, high-quality results. By combining operational robustness with customer-centric product development and collaborative validation pathways, organizations can capture greater strategic value from the expanding role of short-read sequencing in science and medicine.

Transparent research methodology combining primary interviews, secondary source triangulation, and cross-segmentation analysis to ensure reliable and actionable insights

The research underpinning this analysis integrates qualitative and quantitative approaches to ensure robust, reproducible insights. Primary research included structured interviews with executives, laboratory directors, procurement leads, and technical specialists across academic, clinical, and commercial institutions. These interviews provided firsthand perspectives on adoption drivers, validation requirements, procurement behaviors, and operational pain points, which informed thematic synthesis and scenario analysis.

Secondary research encompassed peer-reviewed literature, regulatory guidance documents, company technical specifications, white papers, and public disclosures that describe technological capabilities, workflow performance metrics, and deployment case studies. Comparative evaluation of these sources enabled triangulation of product characteristics, application suitability, and commercial strategies. Where appropriate, supplier documentation and open data repositories were cross-referenced to validate performance claims and identify reproducibility considerations.

Analytical methods included cross-segmentation mapping to reveal alignment between product offerings and application needs, sensitivity assessments to explore the operational impact of policy and supply chain shifts, and stakeholder impact mapping to prioritize recommendations. Rigorous quality controls-such as interview validation, source corroboration, and iterative peer review-were applied throughout the research lifecycle to maintain accuracy and practical relevance for decision-makers.

Concluding synthesis that connects technological maturity, operational resilience, and collaborative strategies to realize the value of short-read sequencing

In conclusion, short-read sequencing stands at the intersection of mature technical capability and expanding application breadth, offering a pragmatic balance between accuracy, throughput, and established analytical ecosystems. The technology's continued refinement in reagents, instrument automation, and data analysis is broadening its applicability from core research laboratories to clinical and industrial settings. Simultaneously, external forces such as regulatory evolution and tariff-driven supply chain adjustments are prompting stakeholders to adopt more resilient procurement and validation practices.

The cumulative picture is one of steady integration: vendors that deliver interoperable, validated workflows and resilient supply strategies will realize greater adoption, while customers that prioritize standardized processes and training will extract more consistent value from their investments. Strategic partnerships across manufacturers, service providers, and end users accelerate the translation of sequencing capabilities into actionable insights for diagnostics, drug discovery, and public health surveillance. By aligning technological choices with operational realities and regulatory requirements, organizations can harness short-read sequencing to advance scientific goals and clinical outcomes.

This document synthesizes the core dynamics shaping the ecosystem and outlines practical steps for stakeholders seeking to optimize technology selection, supply continuity, and application deployment in the near term and beyond.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Short-read Sequencing Market, by Product

  • 8.1. Consumables
    • 8.1.1. Flow Cells & Reagents
    • 8.1.2. Library Prep Kits
  • 8.2. Instruments
    • 8.2.1. Benchtop Sequencers
    • 8.2.2. High-Throughput Sequencers
  • 8.3. Software & Services
    • 8.3.1. Bioinformatics Services
    • 8.3.2. Data Analysis Software

9. Short-read Sequencing Market, by Technology

  • 9.1. Semiconductor Sequencing
    • 9.1.1. Ion Proton
    • 9.1.2. Ion Torrent PGM
  • 9.2. Sequencing Ligation
  • 9.3. Sequencing Synthesis

10. Short-read Sequencing Market, by End User

  • 10.1. Academic & Research Institutes
  • 10.2. Contract Research Organizations
  • 10.3. Hospitals & Diagnostic Labs
  • 10.4. Pharma & Biotech Companies

11. Short-read Sequencing Market, by Application

  • 11.1. Epigenomics
    • 11.1.1. Chromatin Accessibility Analysis
    • 11.1.2. DNA Methylation Analysis
  • 11.2. Genomics
    • 11.2.1. Resequencing
    • 11.2.2. Targeted Sequencing
    • 11.2.3. Whole Genome Sequencing
  • 11.3. Metagenomics
  • 11.4. Transcriptomics

12. Short-read Sequencing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Short-read Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Short-read Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Short-read Sequencing Market

16. China Short-read Sequencing Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. BGI Genomics Co., Ltd.
  • 17.7. Bio-Rad Laboratories, Inc.
  • 17.8. Danaher Corporation
  • 17.9. Eppendorf SE
  • 17.10. Eurofins Scientific SE
  • 17.11. F. Hoffmann-La Roche Ltd
  • 17.12. GE HealthCare Technologies Inc.
  • 17.13. Genewiz, Inc.
  • 17.14. Hamilton Company
  • 17.15. Illumina, Inc.
  • 17.16. Macrogen, Inc.
  • 17.17. Novogene Co., Ltd.
  • 17.18. Oxford Nanopore Technologies plc
  • 17.19. Pacific Biosciences of California, Inc.
  • 17.20. PerkinElmer, Inc.
  • 17.21. Psomagen, Inc.
  • 17.22. Qiagen N.V.
  • 17.23. Takara Bio Inc.
  • 17.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. GCC SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. GCC SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 234. G7 SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. G7 SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. G7 SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. NATO SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 245. NATO SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. NATO SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. NATO SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 248. NATO SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)